Prospective randomised controlled trial of video assisted cytoreductive pleurectomy compared to talc pleurodesis in patients with suspected or proven mesothelioma

ISRCTN ISRCTN34321019
DOI https://doi.org/10.1186/ISRCTN34321019
ClinicalTrials.gov number NCT00821860
Secondary identifying numbers 2.0
Submission date
12/02/2004
Registration date
16/03/2004
Last edited
13/02/2018
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

http://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-treatment-for-fluid-around-the-lung-caused-by-mesothelioma

Contact information

Dr Vikki Hughes
Scientific

Papworth Hospital
Papworth Everard
Cambridge
CB23 3RE
United Kingdom

Phone +44 (0)148 036 4821
Email victoria.hughes@papworth.nhs.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleProspective randomised controlled trial of video assisted cytoreductive pleurectomy compared to talc pleurodesis in patients with suspected or proven mesothelioma
Study acronymMesoVATS
Study objectivesThe MesoVATS trial is a randomised phase III study comparing surgical pleurectomy and palliative pleurodesis to determine which is the better at preventing fluid recurrence.

On 15/02/2011 the overall trial end date was changed from 31/12/2009 to 30/06/2012.
On 25/01/2012 the overall trial end date was changed from 30/06/2012 to 30/12/2012.
Ethics approval(s)Ethics approval received from the local medical ethics committee (LREC) (ref: H02/809)
Health condition(s) or problem(s) studiedMesothelioma
InterventionGroup 1 - pleurodesis:
A procedure in which a chest tube is placed between the lungs and chest wall, and fluid is drained from the intrapleural space. A talc substance will then be administered through the tube. The chest tube will most likely stay in place for a few days following this procedure, and patients will remain hospitalised for about a week.

Group 2 - Video-Assisted Thoracoscopic (VATS) pleurectomy:
A chest tube will be inserted between the lungs and chest wall, and fluid will be drained. Surgery will then be performed to remove the pleural membrane. This is done under general anesthetic, and the chest tube will remain in place for up to 10 days. Patients will remain hospitalised for up to two weeks.
Intervention typeProcedure/Surgery
Primary outcome measure1. Survival at 1 year
2. Control of effusion
3. Quality of life
Secondary outcome measuresNo secondary outcome measures
Overall study start date01/09/2003
Completion date30/12/2012

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants196
Key inclusion criteria1. Proven or suspected mesothelioma
2. Pleural tumour with associated pleural effusion
3. Fit enough for Video-Assisted Thoracoscopic (VATS) pleurectomy
4. Patients who have had a previous malignancy for which they are no longer receiving treatment, provided they have a confirmed diagnosis of mesothelioma
Key exclusion criteria1. Patients who are unfit for a VATS procedure
2. Patients who have had previous attempted pleurodesis
3. Patients without a pleural effusion
Date of first enrolment01/09/2003
Date of final enrolment06/01/2012

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Papworth Hospital
Cambridge
CB23 3RE
United Kingdom

Sponsor information

Papworth Hospital NHS Foundation Trust (UK)
Hospital/treatment centre

Papworth Everard
Cambridge
CB3 8RE
England
United Kingdom

Website http://www.papworthpeople.com/
ROR logo "ROR" https://ror.org/01qbebb31

Funders

Funder type

Industry

British United Provident Association (BUPA) (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 20/09/2014 Yes No

Editorial Notes

MW 13/02/2018: Publication reference added.